US4370338A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Medicament based on 2-amino-6-trifluoromethoxy-benzothiazole
Assignee: Pharmindustrie
•
Filing: 1981-10-05
•
Granted: 1983-01-25
•
Expires: 2001-10-05
Abstract
Abstract Anticonvulsant, anxiolytic and hypnotic medicament containing, as active substance, 2-amino-6-trifluoromethoxy-benzothiazole or a salt of this compound with a pharmaceutically acceptable acid.
Inventors
- 👤 Jacques Mizoule
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 23:20
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/425; A61P; A61P25/00; A61P25/08; A61P25/20; C; C07; C07D; C07D277/00; C07D277/60; C07D277/62; C07D277/68; C07D277/82
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
40 words
A medicament, particularly useful as an anticonvulsant, anxiolytic and hypnotic, which contains a pharmaceutically acceptable vehicle and, as active substance, 1 to 50 mg per unit dose of 2-amino-6-trifluoromethoxy-benzothiazole or a salt of this compound with a pharmaceutically acceptable acid.
Claim 2
Dependent Claim
40 words
A medicament, particularly useful as an anticonvulsant, anxiolytic and hypnotic, which contains a pharmaceutically acceptable vehicle and, as active substance, 1 to 50 mg per unit dose of 2-amino-6-trifluoromethoxy-benzothiazole or a salt of this compound with a pharmaceutically acceptable acid.
Claim 3
Dependent Claim
27 words
A medicament according to claim 1 wherein the pharmaceutically acceptable acid is selected from the group consisting of hydrochloric, hydrobromic, sulfuric, nitric, phosphoric, methanesulfonic and ethanedisulfonic acids.
Claim 4
Dependent Claim
22 words
A medicament according to claim 1 in the form of a compressed tablet containing 10 mg to 50 mg of active substance.
Claim 5
Dependent Claim
19 words
A medicament according to claim 1 in the form of a gelatin-coated pill containing 25 mg of active substance.
Claim 6
Dependent Claim
18 words
A medicament according to claim 1 in the form of a suppository containing 10 mg of active substance.
Claim 7
Dependent Claim
35 words
A process for treating a human suffering from convulsions or anxiety which comprises orally administering to said human 5 to 250 mg per day of 2-amino-6-trifluoromethoxy-benzothiazole or a salt thereof with a pharmaceutically acceptable acid.
Claim 8
Dependent Claim
35 words
A process for treating a human suffering from convulsions or anxiety which comprises orally administering to said human 5 to 250 mg per day of 2-amino-6-trifluoromethoxy-benzothiazole or a salt thereof with a pharmaceutically acceptable acid.
Claim 9
Dependent Claim
27 words
A process according to claim 6 wherein the pharmaceutically acceptable acid is selected from the group consisting of hydrochloric, hydrobromic, sulfuric, nitric, phosphoric, methanesulfonic and ethanedisulfonic acids.
References Cited (Backward Citations)
US3879531A
Cited
US3876653A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-01-24 | 1986-07-26 | 1987-01-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-01-24 | 1990-07-26 | 1991-01-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-01-24 | 1994-07-26 | 1995-01-25 | $7700.00 | Window Closed / Lapsed |